Status:
UNKNOWN
Study of Absorbable Biosynthetic Meshes in Contaminated Ventral Hernia Repair
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Ventral Hernia Repair
Eligibility:
FEMALE
18+ years
Brief Summary
The potential value of biological and biosynthetic meshes is their ability to integrate and remodel the wall in a contaminated environment in complex surgical situations. However, postoperative morbid...
Eligibility Criteria
Inclusion
- Male or female adult patient ( ≥18 years)
- Patient who has agreed to the use of his medical data for the purposes of this research,
- Patient having been operated between May 2016 and September 2018 in a programmed or urgent surgery, as part of clean / contaminated to dirty surgery at mVHWG grade 3 in the centers participating in the study,
- Patient who benefited between May 2016 and September 2018 from a biosynthetic mesh
Exclusion
- Patient who has not consented to the use of her medical data for the purposes of this research,
- Patients who have benefited from the placement of a Phasix® ST biosynthetic mesh in intraperitoneal or Phasix® in retro-muscular prophylaxis,
- Patient under safeguard of justice,
- Patient under guardianship or curatorship.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04132986
Start Date
April 1 2019
End Date
June 30 2023
Last Update
December 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de chirurgie générale et digestive
Strasbourg, France, 67098